Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11772268 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study
Condition: Migraine Without Aura Prophylaxis
Intervention: Drug: Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injection

Indicates status has not been verified in more than two years